Claritas Rx
PrivateLast Round
Series A
Mar 9, 2021
Total Funding Raised
$17.46M
Company Overview
Claritas Rx operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Series A round in March 2021.
Claritas Rx is a healthcare technology company that provides a data integration and analytics platform designed for biopharmaceutical manufacturers to track specialty drug performance and patient journeys.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Data Integration, Patient Engagement, Pharma Supply Chain, CRM
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Claritas Rx Comparables
Compare Claritas Rx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ConcertAI | 84% | |
| Prospection | 79% | |
| IntegriChain | 79% |
For institutional investors. Book with your work email.
Claritas Rx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 9, 2021 | ||||
| Seed | Jul 1, 2020 | ||||
| Debt | Apr 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Claritas Rx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Questa Capital | Series A |
| Kiplin Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 103% MoM, reaching 12.2K.
- Apr 20, 2026
Launched Omnichannel CRM to transform patient services.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresOct 13, 2026
On Oct 13th '26, Claritas Rx appoints biopharma commercial leader Jonathan Witt to its Board of Directors in California, bringing more than 25 years of biopharmaceutical experience.
- receives_awardSep 2, 2026
Claritas Rx wins the Fierce AI Innovation Award for Omnichannel Engagement Strategy in California on Sep 2nd '26, recognizing Patient Watchtower(TM) and Patient Services Omnichannel CRM for turning predictive signals into coordinated action across the patient journey.
- recognized_asAug 11, 2026
Claritas Rx is named to the 2026 Inc. 5000 list by Inc. for the second consecutive year, joining America's fastest-growing private companies, in California on Aug 11th '26.
For institutional investors. Book with your work email.
Claritas Rx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Claritas Rx's valuation, stock price, and market status.
Is Claritas Rx a public or private company?
Claritas Rx is a private company.
What is the current stock price of Claritas Rx?
Claritas Rx is a private company, so its shares have no public market price. Caplight tracks Claritas Rx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Claritas Rx worth (valuation)?
Valuation information for Claritas Rx is not publicly available.
Can I buy Claritas Rx stock?
Claritas Rx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Claritas Rx's last funding round?
Claritas Rx's most recent funding round was Series A on March 9, 2021.
Who are the main investors in Claritas Rx?
Key investors in Claritas Rx include Questa Capital.
Will Claritas Rx IPO soon?
No public IPO plans have been announced for Claritas Rx.
How can I track Claritas Rx secondary market activity?
Caplight tracks bids, offers, and trades in Claritas Rx's shares on secondary markets.